| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 12,780 | $30 | $434.4K |
| J0897 | Injection, denosumab, 1 mg | 8,280 | $20 | $149K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 34,400 | $1 | $137.6K |
| J9312 | Injection, rituximab, 10 mg | 2,200 | $60 | $134.2K |
| J3262 | Injection, tocilizumab, 1 mg | 24,120 | $10 | $120.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,230 | $30 | $84K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 680 | $90 | $61.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 380 | $100 | $37.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 170 | $60 | $9.6K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 160 | $20 | $3.4K |